Skip to Main Content

Paper Details

Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
Transfusion
0
2022
JAK2, K, Kell, MDS, Myelodysplastic syndrome, RBC, RBC alloimmunization, RBC alloimmunized group, Rh, alloimmunization, alloimmunized, genetic abnormalities, genetic abnormality, human, human leukocyte antigen, immune-mediated platelet refractoriness, marrow failure disease, myelodysplastic syndrome, patient, patients, red, red blood cell, red blood cell (RBC) alloimmunization
Erythrocytes, HLA Antigens, Humans, Myelodysplastic Syndromes
Author NameAffiliation
Brian D AdkinsUniversity of Virginia Health System
Margaret SeleskyUniversity of Virginia Health System
Stephany L VittitowUniversity of Virginia Health System
Mark E SmolkinUniversity of Virginia Health System
Sarah J Ratcliffe (CM4AI)University of Virginia Health System
Chance John LuckeyUniversity of Virginia Health System
  • 1 - 6

Datasets

Release 1.2